With a key provision of the Affordable Care Act possibly on the chopping block, MassDevice
looks at how the medical device and biotechnology industries will fare
if the U.S. Supreme Court strikes down any of Obamacare's provisions.

Kevin Outterson, director of Boston University's Health Law Program and a blogger on health policy at The Incidental Economist, told MassDevice.com that unless the most conservative position prevails, there will be a separate fight to determine how the Supremes' ruling will impact the sweeping reforms contained in the President Barack Obama's landmark legislation.
No comments:
Post a Comment